Stock TTOO T2 BIOSYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
3.72 USD +1.92% Intraday chart for T2 Biosystems, Inc. +30.99% -40.72%
04-29 Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating MT
04-23 Top Premarket Decliners MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
AQ
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
AQ
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
AQ
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
AQ
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
AQ
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
AQ
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
AQ
U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
AQ
T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients
AQ
T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing
AQ
T2 Biosystems: Q3 Earnings Snapshot
AQ
T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
AQ
T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
AQ
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
AQ
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TTOO Stock
  4. News T2 Biosystems, Inc.
  5. Press Releases